Aladtm2a(EUCOMM)Wtsi
Targeted Allele Detail
|
Symbol: |
Aladtm2a(EUCOMM)Wtsi |
Name: |
aminolevulinate, delta-, dehydratase; targeted mutation 2a, Wellcome Trust Sanger Institute |
MGI ID: |
MGI:4456011 |
Gene: |
Alad Location: Chr4:62427406-62438155 bp, - strand Genetic Position: Chr4, 33.17 cM
|
IMPC: |
Alad gene page |
|
Mutant Cell Lines: |
EPD0204_3_A09, EPD0204_3_A11, EPD0204_3_A12, EPD0204_3_B10, EPD0204_3_B11, EPD0204_3_B12, EPD0204_3_C10, EPD0204_3_D09, EPD0204_3_D12, EPD0204_3_E09, EPD0204_3_E10, EPD0204_3_E11, EPD0204_3_F12, EPD0204_3_G12, EPD0204_3_H11 |
Germline Transmission: |
Unknown
|
Parent Cell Line: |
JM8.F6 (ES Cell)
|
Strain of Origin: |
C57BL/6N
|
Project Collection: |
EUCOMM
|
|
Allele Type: |
|
Targeted (Conditional ready, Null/knockout, Reporter) |
Mutation: |
|
Insertion
Vector: L1L2_Bact_P
|
|
|
Mutation details: The L1L2_Bact_P cassette was inserted at position 62430822 of Chromosome 4 upstream of the critical exon(s) (Build GRCm39). The cassette is composed of an FRT site followed by lacZ sequence and a loxP site. This first loxP site is followed by a neomycin resistance gene under the control of the human beta-actin promoter, SV40 polyA, a second FRT site and a second loxP site. A third loxP site is inserted downstream of the targeted exon(s) at position 62431460. The critical exon(s) is/are thus flanked by loxP sites. A "conditional ready" (floxed) allele can be created by flp recombinase expression in mice carrying this allele. Subsequent cre expression results in a knockout mouse. If cre expression occurs without flp expression, a reporter knockout mouse will be created. Further information on targeting strategies used for this and other IKMC alleles can be found at http://www.informatics.jax.org/mgihome/nomen/IKMC_schematics.shtml
(J:155845, J:173534)
|
|
|
|
Original: |
J:155845 Wellcome Trust Sanger Institute, Alleles produced for the EUCOMM and EUCOMMTools projects by the Wellcome Trust Sanger Institute. MGI Direct Data Submission. 2010; |
All: |
2 reference(s) |
|